Celldex Therapeutics, Inc.
$39.12
-1.34 (-3.31%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +1.6%
- 3 Months
- +24.5%
- YTD
- +44.0%
- 1 Year
- +73.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 51.1%
- Largest decline max drawdown, since Aug 2025
- -24.2%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.32
Own CLDX?
See how CLDX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.